Japan Animal Health Market Size, Share, and COVID-19 Impact Analysis, By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others), and Japan Animal Health Market Insights, Industry Trend, Forecasts to 2035

Japan Animal Health Market Insights Forecasts to 2035

• The Japan Animal Health Market Size Was Estimated at USD 2,723.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 6.24% from 2025 to 2035
• The Japan Animal Health Market Size is Expected to Reach USD 5,301.8 Million by 2035

According to a research report published by Spherical Insights & Consulting, the Japan animal health market is anticipated to reach USD 5,301.8 million by 2035, growing at a CAGR of 6.24% from 2025 to 2035. The Japan animal health market is developing due to increasing pet ownership, rising awareness of the health of animals, and advancements in veterinary medicine. The sector also develops with a stable pharmaceutical industry and a government focus on the well-being of animals and food safety.

Market Overview

The animal health market for Japan defines the products and services for nutrition and promotion of animal health, including pharmaceuticals, diagnostics, and preventive measures. It provides for companion animals, such as pets, and livestock, such as cattle, poultry, and pigs. The market's competitive advantage is the robust infrastructure, skilled workforce, and consumer demand for high-quality animal health products. Market growth drivers are growing pet ownership, growing awareness of animal welfare, and advances in the veterinary medicine field. Technology developments, including AI diagnostics and telemedicine, are making veterinary services more quality-focused and accessible. Government policies, such as the Act on Welfare and Management of Animals, promote animal welfare and regulate veterinary products to ensure quality and safety.

Report Coverage

This research report categorizes the market for the Japan animal health market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan animal health market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan animal health market.

Driving Factors

The Japan animal health market is driven by increased pet ownership, greater awareness of the well-being of animals, and increased demand for quality veterinary care. Technological advancements, such as AI-based diagnostics and telemedicine, are enhancing efficiency and convenience. Government policy promoting well-being and animal development in livestock sectors also supports market expansion. The increased demand for preventive medicine and specialty therapy also fuels demand within companion and farm animals.

Restraining Factors

The Japan animal health market is restrained by high veterinary costs, strict regulatory clearances, poor access in rural areas, and a lack of skilled veterinary professionals, which limits broader access to services. The aging population of animals increases the prevalence of chronic conditions that need ongoing treatment and medication, which becomes expensive for pet owners as well as veterinary clinics.

Market Segmentation

The Japan animal health market share is classified into product, animal, and end user.

• The drugs segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan animal health market is segmented by product into drugs, vaccines, feed, and diagnostics. Among these, the drugs segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the rising prevalence of various illnesses among animals and the growing prescription for their treatment. These drugs are required to regulate, maintain, and eradicate animal disease.

• The companion animals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan animal health market is segmented by animal into livestock animals and companion animals. Among these, the companion animals segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to the increase in the trend of keeping a pet at home. The increasing rate of adoption of pets to take care of the elderly & physically challenged people, and a trend shift towards pet fostering from pet owners.

• The veterinary hospitals & clinics segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan animal health market is segmented by end user into veterinary hospitals & clinics, animal care & rehabilitation centers, diagnostic centers, and others. Among these, the veterinary hospitals & clinics segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to the increased number of clinics and pet hospitals, along with awareness regarding the spread of zoonotic diseases, which has driven the growth of the veterinary hospitals & clinics segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan animal health market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Nippon Boehringer Ingelheim Co. Ltd.
• Kyoritsu Seiyako
• NIPPON ZENYAKU KOGYO CO., LTD.
• Virbac
• Elanco Animal Health Incorporated
• Nisseiken Co., Ltd.
• Neogen Corporation
• DS Pharma Animal Health Co.
• Vetoquinol Japan Co., Ltd.
• Zoetis Japan
• Ceva Animal Health
• Vetoquinol
• Others

Recent Developments:

• In November 2023, Nippon Zenyaku Kogyo Co., Ltd. (ZENOAQ) entered into a licensing agreement with epitoMAP Inc. and Animal Allergy Clinical Laboratories Inc. for a veterinary antibody pharmaceutical called CRE-DR-B, intended for use in treating allergic diseases like canine atopic dermatitis in Japan, according to Indo-Asian News Service (IANS).

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan animal health market based on the below-mentioned segments:

Japan Animal Health Market, By Product

• Drugs
• Vaccines
• Feed
• Diagnostics

Japan Animal Health Market, By Animal

• Livestock Animals
• Companion Animals

Japan Animal Health Market, By End User

• Veterinary Hospitals & Clinics
• Animal Care & Rehabilitation Centers
• Diagnostic Centers
• Others